Abstract:The spike (S) and nucleocapsid (N) proteins, which are responsible for viral binding to cell surface receptors and the formation of ribonucleoprotein complexes during virion assembling, are major structure proteins of severe acute respiratory syndrome coronavirus (SARS-CoV). The expression of recombinant protein may give more accurate result for detecting SARS-CoV infection. A novel fusion protein,comprising of two fragments of N and S proteins from SARS-CoV, was prepared. Our computer-assisted analysis suggested that the immunodominant domains were located in the amino acid residues 1-227 of N protein and 450-650 of S protein, further the fusion of the two fragments did not change the immunochemical characteristics. The complementary DNA(cDNA) encoding N1-227 fused with S450-650 was obtained by sequence overlapping extension (SOE), and named NLS. It was cloned into pET-28a ( + ), an expression vector for His-tag fusion protein. This new constructed fusion protein was prokaryotic expressed in E. coli,and purified by metal chelate affinity chromatography with the purity over 95 %. The purified fusion protein was identified by anti-His monoclonal antibody and convalescence SARS patients serum. The NLS protein based ELISA showed that NLS maintained appropriate antigenicity and specificity to react with the sera of convalescent SARS patients. The functional NLS protein were successfully expressed and purified. And the fusion protein based ELISA can be used for detection of antibodies (Abs) against the S and N proteins of SARS-CoV. It may provided a novel diagnostic tool and have the potential application in developing of anti-SARS vaccine.

The Cloning, Expression and Activity Assay of N Protein of SARS Coronavirus

Preparation and Preliminary Application of Recombinant Severe Acute Respiratory Syndrome Coronavirus (Sars-Cov) N Protein

Cloning, Expression, Purification of a Fusion Protein of SARS-CoV Nucleocapsid and Spike Protein Fragments and Its Immunological Characteristics

Expression and Application of SARS Coronavirus N Gene

Construction of Prokaryotic Recombinant Vector of SARS Coronavirus N Protein and Its Expression

Expression, Purification and Antigen Analysis of SARS-associated Coronavirus Nucleocapsid Protein in Pichia Pastoris System

Preparation of Specific Monoclonal Antibody Against Nucleocapsid Protein of SARS Coronavirus

Preliminary study on cloning and expression of full-length SARS-CoV S protein

[Expression and Purification of Recombinant N-terminal Protein of SARS S1 Subunit Expressed in E. Coli].

Expression and purification of recombinant SARS-CoV-2 nucleocapsid protein in inclusion bodies and its application in serological detection

Cloning of Protein M Encoding Gene of SARS-Coronavirus(SARS-CoV)and Its Expression in E.coli

[The Cloning, Expression, Purification and Identification of SARS Virus S2 Gene and Study on Its Immunological Characteristics].

Prokaryotic Expression of Different Regions of SARS-CoV Nucleocapsid Protein

[Expression of the Recombinant SARS Coronavirus Nucleocapsid Protein in Pichia Pastoris and Identification of Its Bioactivity].

Antigenicity Identification and Gene Immunization of SARS-coronavirus Nucleocapsid Protein

Cloning and Expression of SARS-CoV S2 Protein Gene in Vero E6 Cells

Expression and Identification of SARS-CoV Nucleocapsid Protein

The C-terminal portion of the nucleocapsid protein demonstrates SARS-CoV antigenicity.

Expression, purification and sublocalization of SARS-CoV nucleocapsid protein in insect cells.

Comparison of Effectiveness of Whole Viral, N and N199 Proteins by ELISA for the Rapid Diagnosis of Severe Acute Respiratory Syndrome Coronavirus

Expression and purification S protein of SARS-CoV